T1	Intervention 492 665	subjects received capsules with supplemental sodium (3 g d(-1), equals 7.6 g d(-1) of salt), supplemental potassium (3 g d(-1)) or placebo, for 4 weeks each, in random order
T2	Intervention 667 783	Fasting office BP, 24-h ambulatory BP and measures of arterial stiffness were assessed at baseline and every 4 weeks
T3	Intervention 372 460	subjects were on a fully controlled diet that was relatively low in sodium and potassium
